drugset / Trial / NCT02667561
Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%
RandomizedParallel-groupOpen-labelOther
Summary
This is a Phase I, open-label, parallel trial to evaluate Pharmacokinetics, Pharmacodynamics and Safety of Testosterone gel 1% for topic usage in post-menopausal women, for 28 days
Timeline
- Start
- 2017-07
- Primary completion
- 2017-12
- Completion
- 2018-05
Outcome
Outcome not reported
Stopped: “Study has been cancelled and it has not been initiated.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Testosterone | Small molecule | 2.2 mg | Topical |
| Subject | Testosterone | Small molecule | 4.4 mg | Topical |
| Subject | Testosterone | Small molecule | 8.8 mg | Topical |
Indications
No indication recorded.